Published in Science on December 22, 1989
Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc Natl Acad Sci U S A (1990) 4.63
Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol (1993) 3.90
Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc Natl Acad Sci U S A (1991) 3.06
The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol Cell Biol (1992) 2.83
Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J Virol (1991) 2.30
Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol (1994) 2.29
Minimal Rev-response element for type 1 human immunodeficiency virus. J Virol (1991) 2.22
Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J Virol (1994) 2.20
Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. Proc Natl Acad Sci U S A (1991) 2.19
Substrate specificity of the dsRNA unwinding/modifying activity. EMBO J (1991) 2.18
Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res (1991) 1.96
Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc Natl Acad Sci U S A (1992) 1.96
Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure. J Virol (1990) 1.94
Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of human immunodeficiency virus type 1. J Virol (1990) 1.90
Specific binding of a basic peptide from HIV-1 Rev. EMBO J (1992) 1.84
The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc Natl Acad Sci U S A (1991) 1.68
The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. J Virol (1993) 1.65
Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus. J Virol (1992) 1.64
Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J Virol (1993) 1.45
Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein. J Virol (1992) 1.43
Selective optimization of the Rev-binding element of HIV-1. Nucleic Acids Res (1993) 1.40
Functional comparison of transactivation by human retrovirus rev and rex genes. J Virol (1990) 1.27
Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex. J Virol (1991) 1.27
A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals. Proc Natl Acad Sci U S A (1994) 1.26
The Rex regulatory protein of human T-cell lymphotropic virus type I binds specifically to its target site within the viral RNA. Proc Natl Acad Sci U S A (1991) 1.26
Rev-dependent expression of human immunodeficiency virus type 1 gp160 in Drosophila melanogaster cells. Mol Cell Biol (1990) 1.25
Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA. J Virol (1990) 1.24
Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol (1995) 1.23
Resistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element. Proc Natl Acad Sci U S A (2008) 1.22
RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo. J Virol (1996) 1.22
Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J Virol (1995) 1.20
Genetic regulation of human immunodeficiency virus. Microbiol Rev (1991) 1.18
Rex transregulation of human T-cell leukemia virus type II gene expression. J Virol (1991) 1.07
Role of RNA helicases in HIV-1 replication. Nucleic Acids Res (2006) 1.06
cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations. J Virol (1996) 1.03
Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm. J Virol (1994) 1.01
Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins. J Virol (2006) 0.99
The HIV-1 Rev response element: an RNA scaffold that directs the cooperative assembly of a homo-oligomeric ribonucleoprotein complex. RNA Biol (2012) 0.99
Mutational analysis of the human T-cell leukemia virus type I trans-acting rex gene product. J Virol (1991) 0.97
Localization of HIV-1 RNA in mammalian nuclei. J Cell Biol (1996) 0.95
Selection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 protein. J Virol (1999) 0.94
An intrabody based on a llama single-domain antibody targeting the N-terminal alpha-helical multimerization domain of HIV-1 rev prevents viral production. J Biol Chem (2010) 0.91
In vivo binding of wild-type and mutant human immunodeficiency virus type 1 Rev proteins: implications for function. J Virol (1992) 0.90
Clinical applications involving CNS gene transfer. Adv Genet (2014) 0.89
Methods for gene transfer to the central nervous system. Adv Genet (2014) 0.88
Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides. J Virol (1992) 0.88
Overlapping messages and survivability. J Mol Evol (2004) 0.87
LC3-mediated fibronectin mRNA translation induces fibrosarcoma growth by increasing connective tissue growth factor. J Cell Sci (2009) 0.85
The HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication. Nucleic Acids Res (2015) 0.83
Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function. J Virol (2011) 0.83
A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev. Nucleic Acids Res (1994) 0.83
Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer. RNA Biol (2011) 0.82
Human chromosome 6- and 11-encoded factors support human immunodeficiency virus type 1 Rev function in A9 cells. J Virol (1996) 0.82
The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism. J Virol (1993) 0.81
Hidden messages in the nef gene of human immunodeficiency virus type 1 suggest a novel RNA secondary structure. Nucleic Acids Res (2003) 0.81
RNA tertiary structure of the HIV RRE domain II containing non-Watson-Crick base pairs GG and GA: molecular modeling studies. Nucleic Acids Res (1994) 0.80
The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells. J Virol (1996) 0.80
Robust growth of human immunodeficiency virus type 1 (HIV-1). Biophys J (2005) 0.78
Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export. Retrovirology (2014) 0.76
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell (1986) 10.76
Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. Nature (1986) 5.24
Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science (1986) 3.80
In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection. J Infect Dis (2008) 1.67
A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1984) 1.55
Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein. J Virol (1992) 1.43
Primary laparoscopic-assisted endorectal colon pull-through for Hirschsprung's disease: a new gold standard. Ann Surg (1999) 1.23
Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. J Biomed Sci (2001) 1.20
Bedside tracheostomy in the intensive care unit: a prospective randomized trial comparing open surgical tracheostomy with endoscopically guided percutaneous dilational tracheotomy. Laryngoscope (2001) 1.19
A specific replication origin in the chromosomal rDNA of Lytechinus variegatus. Nature (1982) 1.12
Development of Dengue virus type 2 replicons capable of prolonged expression in host cells. BMC Microbiol (2001) 1.02
Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection. Eur J Immunol (1991) 0.99
Persistence of aldicarb in soil relative to the carry-over of residues into crops. J Agric Food Chem (1982) 0.97
Quantification of the learning curve for percutaneous dilatational tracheotomy. Laryngoscope (2000) 0.97
The management of choledocholithiasis in children in the era of laparoscopic cholecystectomy. J Pediatr Surg (1997) 0.93
Skin infections in Tanna, Vanuatu in 1989. P N G Med J (1992) 0.93
Sequence specificity in the higher-order interaction of the Rev protein of HIV-1 with its target sequence, the RRE. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.93
Tolerance of diverse amino acid substitutions at conserved positions in the nuclear export signal (NES) of HIV-1 Rev. Biochem Biophys Res Commun (1998) 0.92
Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes. Endocrinology (1990) 0.91
Influence of knot configuration and tying technique on the mechanical performance of sutures. J Emerg Med (1991) 0.91
The use of a bioactive skin substitute decreases length of stay for pediatric burn patients. J Pediatr Surg (2001) 0.90
Yaws infection in Tanna, Vanuatu 1989. Southeast Asian J Trop Med Public Health (1991) 0.88
Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo. Cancer Res (1992) 0.86
Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIV. BMC Microbiol (2001) 0.85
Altered membrane structure in transfected mouse L-cell fibroblasts expressing rat liver fatty acid-binding protein. J Biol Chem (1990) 0.83
The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism. J Virol (1993) 0.81
Serological relationships among budding, prosthecate bacteria. Can J Microbiol (1980) 0.81
Characteristics of the myocardial PM-FABP: effect of diabetes mellitus. Mol Cell Biochem (1997) 0.80
Clinical management of intersex abnormalities. Curr Probl Surg (1991) 0.78
Two secondary structures for the RRE of HIV-1? J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.78
Local and systemic toxicity resulting from large-volume ip administration of doxorubicin in the rat. Cancer Treat Rep (1982) 0.78
Video-assisted thoracic surgery (VATS) for children with pulmonary metastases from osteosarcoma. Ann Surg Oncol (1996) 0.75
Senior house officer training: some myths exposed. 1999; 44(5): 324-7. J R Coll Surg Edinb (2000) 0.75
Nucleotide sequences of 5S ribosomal RNAs from three marine eubacteria: Shewanella hanedai, Alteromonas colwelliana and Vibrio mediterranei. Nucleic Acids Res (1989) 0.75
Congenital diaphragmatic hernia. Outcome of preoperative extracorporeal membrane oxygenation. Clin Pediatr (Phila) (1995) 0.75
Modern trends in nursing. Address of welcome. Nurs Mirror Midwives J (1975) 0.75
A new compound-curved needle for microvascular surgery. Ann Plast Surg (1991) 0.75
Concurrence of multiple sclerosis and Hodgkin's disease. J Emerg Med (1992) 0.75
Biochemical performance of tapercut cardiovascular needles. Am Surg (1991) 0.75
Adaptive communication systems for patients with mobility disorders. J Burn Care Rehabil (1991) 0.75
Pesticides for control of the two-spotted spider mite and the onion thrips on potatoes. J Econ Entomol (1966) 0.75
Control of the green peach aphid and suppression of leaf roll on potatoes by systemic soil insecticides and multiple foliar sprays. J Econ Entomol (1973) 0.75
Managing organizational problems in alternative service organizations. Adm Soc Work (1986) 0.75
Clearance of infused triglyceride by resting horses. Comp Biochem Physiol Comp Physiol (1993) 0.75
Potential signals mediating the maintenance of reproductive activity during the non-breeding season of the mare. Reprod Suppl (2002) 0.75
The effect of dietary fibre on hydration status after dehydration with frusemide. Equine Vet J Suppl (1999) 0.75
Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus. Mol Cell Biochem (1995) 0.75
Thoughts on the source of tissue on subsequent cell culture success. Methods Cell Sci (2000) 0.75
Biomechanical performance of tapercut needles for oral surgery. J Oral Maxillofac Surg (1991) 0.75
Endosulfan, oxydemetonmethyl, and endrin in control of the green peach aphid and suppression of leaf roll in potatoes in eastern Washington. J Econ Entomol (1966) 0.75
An insecticide and a defoliant evaluated for use in a program of integrated control designed to suppress the green peach aphid on peach trees. J Econ Entomol (1972) 0.75
Müllerian inhibiting substance blocks epidermal growth factor receptor phosphorylation in fetal rat lung membranes. Metabolism (1991) 0.75